In cancers where high inflammatory stress is usual, protein rich supplements containing n-3 polyunsaturated fatty acids and high levels of antioxidant vitamins can reverse severe weight loss
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
One of the common traits found in cancer patients is malnutrition and cachexia, which affects betwee...
In cancers where high inflammatory stress is usual, protein rich supplements containing n-3 polyunsa...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
The management of cancer patients is frequently complicated by the occurrence of cachexia, a complex...
We provide a systematic review to support the European Palliative Care Research Collaboration develo...
Cancer-related cachexia (CAC) is a syndrome occurring in many cancer patients, with a detrimental ef...
Cancer cachexia is a poorly understood syndrome of anorexia, weight loss, and muscle wasting that ne...
Cachexia is a major problem in many cancer patients with a global incidence of malnutrition ranging ...
Aim: N-3 fatty acids, especially eicosapentaenoic acid (EPA), may possess anticachectic properties. ...
Anorexia and muscle wasting are frequently observed in cancer patients and influence their clinical ...
Cancer-associated malnutrition, or cachexia, stemming from cancer or its treatments, is particularly...
Cancer‐associated malnutrition, or cachexia, stemming from cancer or its treatments, is particularly...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
One of the common traits found in cancer patients is malnutrition and cachexia, which affects betwee...
In cancers where high inflammatory stress is usual, protein rich supplements containing n-3 polyunsa...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
The management of cancer patients is frequently complicated by the occurrence of cachexia, a complex...
We provide a systematic review to support the European Palliative Care Research Collaboration develo...
Cancer-related cachexia (CAC) is a syndrome occurring in many cancer patients, with a detrimental ef...
Cancer cachexia is a poorly understood syndrome of anorexia, weight loss, and muscle wasting that ne...
Cachexia is a major problem in many cancer patients with a global incidence of malnutrition ranging ...
Aim: N-3 fatty acids, especially eicosapentaenoic acid (EPA), may possess anticachectic properties. ...
Anorexia and muscle wasting are frequently observed in cancer patients and influence their clinical ...
Cancer-associated malnutrition, or cachexia, stemming from cancer or its treatments, is particularly...
Cancer‐associated malnutrition, or cachexia, stemming from cancer or its treatments, is particularly...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
One of the common traits found in cancer patients is malnutrition and cachexia, which affects betwee...
DOI
Add to ORKG